Abstract
The allergenicity of two types of whey protein hydrolysates-bacterial protease hydrolysed whey protein (BHW) with a molecular mass less than 3500 and trypsin hydrolysed whey protein (THW) with a molecular mass less than 6500-was compared with that of whey protein concentrate (WPC) or β-lactoglobulin (β-LG) in vivo by their ability to release rat chymase II (RChyII), an indicator of muccsal mast cell degranulation in the intestine. Antigen-specific reaginic activity and immunoglobulin (Ig)G in serum were markedly lower in rats primed with BHW than in those with WPC or β-LG, although these were not lowered in THW-primed rats. In contrast, rats primed with either hydrolysate and subsequently orally challenged with the primed antigen increased the release of RChyII to a greater extent than did rats primed and challenged with the native proteins. The extent of the release was primarily attributed to the nature of primed rather than challenged antigen. These results indicate that determination of circulatory RChyII is a sensitive in vivo method to evaluate the allergenicity of milk protein hydrolysates. The improper hydrolysis of dietary protein may enhance allergic reactions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.